These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1778896)

  • 1. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients.
    Chopra R; Blair S; Strang J; Cervi P; Patterson KG; Goldstone AH
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centre.
    Chopra R; Fielding A; Goldstone AH
    Leuk Lymphoma; 1992; 7 Suppl():73-7. PubMed ID: 1493462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients.
    Mills W; Chopra R; Linch DC; Goldstone AH
    Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data.
    Ng TT; Denning DW
    Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
    Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
    Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients.
    Böhme A; Hoelzer D
    Mycoses; 1996; 39(11-12):419-26. PubMed ID: 9144997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
    Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of comparative studies between conventional and liposomal amphotericin B (Ambisome) in neutropenic patients with fever of unknown origin and patients with systemic mycosis.
    Blau IW; Fauser AA
    Mycoses; 2000 Oct; 43(9-10):325-32. PubMed ID: 11105535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.
    Coukell AJ; Brogden RN
    Drugs; 1998 Apr; 55(4):585-612. PubMed ID: 9561346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
    Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
    N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.
    Ringdén O; Meunier F; Tollemar J; Ricci P; Tura S; Kuse E; Viviani MA; Gorin NC; Klastersky J; Fenaux P
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():73-82. PubMed ID: 1778894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
    J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients.
    Tollemar J; Andersson S; Ringdén O; Tydén G
    Mycoses; 1992; 35(9-10):215-20. PubMed ID: 1291871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections.
    Leenders AC; Daenen S; Jansen RL; Hop WC; Lowenberg B; Wijermans PW; Cornelissen J; Herbrecht R; van der Lelie H; Hoogsteden HC; Verbrugh HA; de Marie S
    Br J Haematol; 1998 Oct; 103(1):205-12. PubMed ID: 9792309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of systemic fungal infections with liposomal amphotericin B.
    Lopez-Berestein G; Bodey GP; Fainstein V; Keating M; Frankel LS; Zeluff B; Gentry L; Mehta K
    Arch Intern Med; 1989 Nov; 149(11):2533-6. PubMed ID: 2818111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
    Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G
    Bone Marrow Transplant; 1993 Dec; 12(6):577-82. PubMed ID: 8136741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.
    Ellis M; Frampton C; Joseph J; Alizadeh H; Kristensen J; Hauggaard A; Shammas F
    J Med Microbiol; 2006 Oct; 55(Pt 10):1357-1365. PubMed ID: 17005784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children.
    Tollemar J; Klingspor L; Ringdén O
    Clin Microbiol Infect; 2001; 7 Suppl 2():68-79. PubMed ID: 11525221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of deep mycoses with liposomal amphotericin B.
    Berenguer J; Muñoz P; Parras F; Fernández-Baca V; Hernández-Sampelayo T; Bouza E
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):504-7. PubMed ID: 7957273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.